文献速递儿科与产科急症重症综合管理与镇静镇痛呼吸衰竭与机械通气

妊娠期新型冠状病毒肺炎的临床表现、危险因素及母婴结局:动态系统评价与Meta分析

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis.
PubMed 文献 · BMJ · 2020-09-01
一句话结论妊娠及近期妊娠合并COVID-19患者症状较少但ICU入住和有创通气风险高于同龄非妊娠妇女,且合并症、高龄、高BMI等为重症危险因素。

该动态系统评价与Meta分析纳入192项队列研究,评估妊娠及近期妊娠妇女疑似或确诊COVID-19的临床表现、危险因素及母婴结局。妊娠合并COVID-19患者发热(40%)和咳嗽(41%)最常见,但较非妊娠育龄妇女更少出现症状(OR 0.28)、发热(OR 0.49)、呼吸困难(OR 0.76)和肌痛(OR 0.53),而ICU入住(OR 2.13)、有创通气(OR 2.59)和ECMO(OR 2.02)风险更高。高龄、高BMI、合并症、慢性高血压、糖尿病和子痫前期与重症相关。与无COVID-19孕妇相比,COVID-19孕妇死亡(OR 2.85)、ICU入住(OR 18.58)和早产(OR 1.47)风险增加,新生儿NICU入住风险更高(OR 4.89)。

要点

  • 妊娠及近期妊娠合并COVID-19患者较非妊娠育龄妇女更少出现症状(OR 0.28)、发热(OR 0.49)、呼吸困难(OR 0.76)和肌痛(OR 0.53),但ICU入住(OR 2.13)、有创通气(OR 2.59)和ECMO(OR 2.02)风险更高。
  • 妊娠合并COVID-19患者最常见的临床表现为发热(40%)和咳嗽(41%)。
  • 高龄(OR 1.83)、高BMI(OR 2.37)、任何既存合并症(OR 1.81)、慢性高血压(OR 2.0)、既存糖尿病(OR 2.12)和子痫前期(OR 4.21)与妊娠期重症COVID-19相关。
  • 与无COVID-19孕妇相比,COVID-19孕妇死亡(OR 2.85)、ICU入住(OR 18.58)和早产(OR 1.47)风险增加,新生儿NICU入住风险更高(OR 4.89)。
  • 妊娠及近期妊娠妇女因任何原因就诊或入院时,疑似或确诊COVID-19的比例为10%(95%CI 7%至12%)。

适用人群与场景

  • 妊娠及近期妊娠妇女,因任何原因就诊或入院,疑似或确诊COVID-19。
  • 纳入标准:报告妊娠及近期妊娠妇女疑似或确诊COVID-19的发病率、临床表现、危险因素及母婴结局的队列研究。

研究设计与关键结果

  • 研究设计:动态系统评价与Meta分析,纳入192项队列研究,检索截至2020年10月6日。
  • 妊娠及近期妊娠妇女因任何原因就诊或入院时,疑似或确诊COVID-19的比例为10%(95%CI 7%至12%;73项研究,67271名妇女)。
  • 妊娠期COVID-19最常见临床表现为发热(40%)和咳嗽(41%)。
  • 与非妊娠育龄妇女相比,妊娠及近期妊娠合并COVID-19者更少出现症状(OR 0.28,95%CI 0.13至0.62;I²=42.9%)、发热(OR 0.49,95%CI 0.38至0.63;I²=40.8%)、呼吸困难(OR 0.76,95%CI 0.67至0.85;I²=4.4%)和肌痛(OR 0.53,95%CI 0.36至0.78;I²=59.4%)。
  • 与非妊娠育龄妇女相比,妊娠及近期妊娠合并COVID-19者ICU入住(OR 2.13,95%CI 1.53至2.95;I²=71.2%)、有创通气(OR 2.59,95%CI 2.28至2.94;I²=0%)和ECMO(OR 2.02,95%CI 1.22至3.34;I²=0%)的比值更高。
  • 确诊COVID-19的妊娠妇女中,全因死亡339例(0.02%,59项研究,41664名妇女)。
  • 与妊娠期重症COVID-19相关的因素:高龄(OR 1.83,95%CI 1.27至2.63;I²=43.4%)、高BMI(OR 2.37,95%CI 1.83至3.07;I²=0%)、任何既存合并症(OR 1.81,95%CI 1.49至2.20;I²=0%)、慢性高血压(OR 2.0,95%CI 1.14至3.48;I²=0%)、既存糖尿病(OR 2.12,95%CI 1.62至2.78;I²=0%)和子痫前期(OR 4.21,95
  • 与无COVID-19孕妇相比,COVID-19孕妇死亡(OR 2.85,95%CI 1.08至7.52;I²=0%)、ICU入住(OR 18.58,95%CI 7.53至45.82;I²=0%)和早产(OR 1.47,95%CI 1.14至1.91;I²=18.6%)的比值更高;其婴儿NICU入住比值更高(OR 4.89,95%CI 1.87至12.81;I²=96.2%)。

证据类型、等级与局限

  • 证据类型:动态系统评价与Meta分析,纳入192项队列研究,采用随机效应模型。
  • 注册号:PROSPERO CRD42020178076。
  • 局限性:各合并估计的异质性较高(如ICU入住I²=71.2%、肌痛I²=59.4%、新生儿NICU入住I²=96.2%);本文为动态系统评价,将定期更新以反映新证据。

对床旁实践的改变

  • 妊娠及近期妊娠合并COVID-19患者可能症状较少,但ICU入住和有创通气风险高于非妊娠育龄妇女,临床评估时不应因症状轻微而低估重症风险。
  • 高龄、高BMI、既存合并症(包括慢性高血压和糖尿病)及子痫前期的妊娠合并COVID-19患者发生重症的风险更高。
  • 与无COVID-19孕妇相比,COVID-19孕妇早产、ICU入住和死亡风险增加,其婴儿NICU入住风险更高。

指南或共识出处

  • BMJ 2020;370:m3320,2020年9月1日首次发表,本文为更新1;动态系统评价注册号PROSPERO CRD42020178076。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To determine the clinical manifestations, risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed coronavirus disease 2019 (covid-19).

DESIGN: Living systematic review and meta-analysis.

DATA SOURCES: Medline, Embase, Cochrane database, WHO COVID-19 database, China National Knowledge Infrastructure (CNKI), and Wanfang databases from 1 December 2019 to 6 October 2020, along with preprint servers, social media, and reference lists.

STUDY SELECTION: Cohort studies reporting the rates, clinical manifestations (symptoms, laboratory and radiological findings), risk factors, and maternal and perinatal outcomes in pregnant and recently pregnant women with suspected or confirmed covid-19.

DATA EXTRACTION: At least two researchers independently extracted the data and assessed study quality. Random effects meta-analysis was performed, with estimates pooled as odds ratios and proportions with 95% confidence intervals. All analyses will be updated regularly.

RESULTS: 192 studies were included. Overall, 10% (95% confidence interval 7% to 12%; 73 studies, 67 271 women) of pregnant and recently pregnant women attending or admitted to hospital for any reason were diagnosed as having suspected or confirmed covid-19. The most common clinical manifestations of covid-19 in pregnancy were fever (40%) and cough (41%). Compared with non-pregnant women of reproductive age, pregnant and recently pregnant women with covid-19 were less likely to have symptoms (odds ratio 0.28, 95% confidence interval 0.13 to 0.62; I2=42.9%) or report symptoms of fever (0.49, 0.38 to 0.63; I2=40.8%), dyspnoea (0.76, 0.67 to 0.85; I2=4.4%) and myalgia (0.53, 0.36 to 0.78; I2=59.4%). The odds of admission to an intensive care unit (odds ratio 2.13, 1.53 to 2.95; I2=71.2%), invasive ventilation (2.59, 2.28 to 2.94; I2=0%) and need for extra corporeal membrane oxygenation (2.02, 1.22 to 3.34; I2=0%) were higher in pregnant and recently pregnant than non-pregnant reproductive aged women. Overall, 339 pregnant women (0.02%, 59 studies, 41 664 women) with confirmed covid-19 died from any cause. Increased maternal age (odds ratio 1.83, 1.27 to 2.63; I2=43.4%), high body mass index (2.37, 1.83 to 3.07; I2=0%), any pre-existing maternal comorbidity (1.81, 1.49 to 2.20; I2=0%), chronic hypertension (2.0, 1.14 to 3.48; I2=0%), pre-existing diabetes (2.12, 1.62 to 2.78; I2=0%), and pre-eclampsia (4.21, 1.27 to 14.0; I2=0%) were associated with severe covid-19 in pregnancy. In pregnant women with covid-19, increased maternal age, high body mass index, non-white ethnicity, any pre-existing maternal comorbidity including chronic hypertension and diabetes, and pre-eclampsia were associated with serious complications such as admission to an intensive care unit, invasive ventilation and maternal death. Compared to pregnant women without covid-19, those with the disease had increased odds of maternal death (odds ratio 2.85, 1.08 to 7.52; I2=0%), of needing admission to the intensive care unit (18.58, 7.53 to 45.82; I2=0%), and of preterm birth (1.47, 1.14 to 1.91; I2=18.6%). The odds of admission to the neonatal intensive care unit (4.89, 1.87 to 12.81, I2=96.2%) were higher in babies born to mothers with covid-19 versus those without covid-19.

CONCLUSION: Pregnant and recently pregnant women with covid-19 attending or admitted to the hospitals for any reason are less likely to manifest symptoms such as fever, dyspnoea, and myalgia, and are more likely to be admitted to the intensive care unit or needing invasive ventilation than non-pregnant women of reproductive age. Pre-existing comorbidities, non-white ethnicity, chronic hypertension, pre-existing diabetes, high maternal age, and high body mass index are risk factors for severe covid-19 in pregnancy. Pregnant women with covid-19 versus without covid-19 are more likely to deliver preterm and could have an increased risk of maternal death and of being admitted to the intensive care unit. Their babies are more likely to be admitted to the neonatal unit.

SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42020178076.

READERS' NOTE: This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication. This version is update 1 of the original article published on 1 September 2020 (BMJ 2020;370:m3320), and previous updates can be found as data supplements (https://www.bmj.com/content/370/bmj.m3320/related#datasupp). When citing this paper please consider adding the update number and date of access for clarity.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020. PMID: 32873575. doi:10.1136/bmj.m3320

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。